Work

Abstract OT1-01-02: A multicenter phase II trial to evaluate the efficacy and safety of pembrolizumab and gemcitabine in patients with HER2-negative advanced breast cancer: GEICAM/2015-04 PANGEA-Breast

Year: 2018

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs17-ot1-01-02

Authors: L de la Cruz, V Sánchez-Margalet, P Berraondo, S Benito, MJ Escudero, R Caballero, E Carrasco, L Galluzzi, F Rojo

Institutions: Hospital Universitario Virgen Macarena, GEICAM – Spanish Breast Cancer Group, Université Paris Descartes, Centro de Investigación Médica Aplicada

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2789631298

Cites:

Cited by: 2

Related to: 10